This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive  Media Kit | Clinical Laboratory Marketplace    

Home   About   Scholarships   Meetings   Publications   Resources   Sep. 25, 2012

 



Disease outbreak in Saudi Arabia linked to SARS
The Canadian Press via the Toronto Star    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The World Health Organization is keeping a close eye on a disease outbreak in Saudi Arabia caused by a virus in the same family as the one that caused SARS. There have been two confirmed infections with the new coronavirus and tests results are pending on a third suspected case, according to media reports from the Middle East. Two of those three people have died. More

We've got you covered
Dealing with infectious samples is risky enough.
Why increase your risk by overlooking transport regulations?

Saf-T-Pak provides the solutions required for 49 CFR compliance:


Black Death: Can the secrets of London's plague pits help fight modern diseases?
NBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefThey were the final resting place for victims of the Black Death, but London's underground medieval plague pits are now unlocking the secrets of modern-day infectious diseases. A conference of forensic scientists will hear how an international team of experts - led by researchers based at McMaster University in Hamilton, Canada, and the University of Tubingen in Germany - sequenced the entire genome of the Black Death using DNA extracted from plague victims. More

Link between chronic fatigue syndrome, viruses disproved
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Xenotropic murine leukemia virus-related virus and polytropic murine leukemia virus are not linked to chronic fatigue syndrome/myalgic encephalomyelitis, according to an article published online in mBio. The new study confirms recent evidence that the associations, initially reported in 2009 (for XMRV) and in 2010 (for pMLV), were erroneous and a result of laboratory contamination. More

Researchers identify possible key to slow progression toward AIDS
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
One of the big mysteries of AIDS is why some HIV-positive people take more than a decade to progress to full-blown AIDS, if they progress at all. Although the average time between HIV infection and AIDS in the absence of antiretroviral treatment is about 10 years, some individuals succumb within two years, while so-called slow progressors can stay healthy for 20 years or longer. More



Breast cancer DNA study yields new targets for therapy
Bloomberg Businessweek    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Genetic mapping of hundreds of breast cancer tumors confirmed there are four main subtypes and discovered that one closely resembles ovarian cancer, suggesting the two may be attacked with similar therapies. The study, in which the genomes of 825 breast tumors were sequenced, was the most comprehensive of its type involving the disease. More

Study finds least aggressive form of breast cancer still poses risk for death years later
Kaiser Permanente via Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Women with the most common and least aggressive subtype of breast cancer were still at risk of death from the disease more than 10 years after diagnosis, according to a Kaiser Permanente study published in the journal Cancer Epidemiology, Biomarkers & Prevention. The 21-year study included nearly 1,000 women from Kaiser Permanente Southern California and found that molecular subtypes of breast cancer were important independent predictors of breast cancer mortality. More

Young women skip mammograms after task force recommendations
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Rates of screening mammography among women younger than 50 declined within two months of a negative recommendation by the U.S. Preventive Services Task Force and have remained below baseline rates, according to a study. The mammography rate among women ages 40 to 49 decreased by almost 8 percent in the period immediately after the 2009 release of the USPSTF recommendation against routine screening mammography for that age group. More


CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

1-800-379-0957. diaginfo@grifols.com
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.


New AAN guideline on diagnosis of sporadic Creutzfeldt-Jakob
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
When sporadic Creutzfeldt-Jakob disease is strongly suspected in a patient with rapidly progressive dementia, clinicians should order cerebrospinal fluid testing for protein 14-3-3, a new evidence-based guideline from the American Academy of Neurology recommends. The guideline, "Diagnostic Accuracy of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease," was published in Neurology. More

Indiana teens among most protected from infectious diseases
WANE-TV    Share    Share on FacebookTwitterShare on LinkedinE-mail article
According to the most recent Centers for Disease Control and Prevention National Immunization Survey for Teens, Indiana teenagers are among the most well protected in the nation from certain infectious diseases. Hoosier teens are first in the nation for meningococcal vaccine coverage and second in the nation for Tdap coverage. More



Procalcitonin can help spot bacterial infection in children
Reuters via Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Pooled data suggest that compared with conventional leukocyte counts and C-reactive protein level, procalcitonin may be better in early identification of febrile children at risk of serious bacterial infection. However, it appears at best to be most accurate in ruling out serious bacterial infection, according to Taiwanese researchers. More

Expansion of Zadroga law covers 50 more cancer types for those who toiled at ground zero
New York Daily News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For years they were alone as their strength was sapped and their bank accounts drained by the cancers they caught at ground zero. Now, finally, New York's 9/11 heroes have gotten some backup. Cancer survivors cheered the government's recent decision to add 50 varieties of the deadly disease to the list of 9/11-linked ailments covered by the Zadroga law – making the sickened heroes eligible to tap the fund for much-needed help. More



A first: Organs tailor-made with body's own cells
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
With a patient suffering from a tumor in his windpipe, Dr. Paolo Macchiarini at the Karolinska Institute in Stockholm, had a radical idea: making the patient a new windpipe, out of plastic and his own cells. Implanting "bioartificial" organs would be a first-of-its-kind procedure for the field of regenerative medicine, which for decades has been promising a future of ready-made replacement organs — livers, kidneys, even hearts — built in the laboratory. Now, researchers are building organs with a different approach, using the body's cells and letting the body itself do most of the work. More

Addictive properties of drug abuse may hold key to HIV cure
Florida State University via Infection Control Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A Florida State University researcher is on a mission to explore the gene-controlling effects of addictive drugs in pursuit of new HIV treatments. Working under the support of a $1.8 million grant from the National Institutes of Health, Florida State biologist Jonathan Dennis is studying a unique ability shared between a promising class of HIV treatments known as histone deacetylase inhibitors and psychostimulant drugs such as cocaine. More
 


ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news


This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Join ASCLS and we will subscribe you -- it's free!

Recent issues

Sept. 24, 2012
Sept. 18, 2012
Sept. 11, 2012
Sept. 4, 2012






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063